Amol Kavishwar

Amol Kavishwar

AbbVie Inc - Chicago / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4402381
-
person_outline Amol Kavishwar's MOST POPULAR ARTICLES
1-) Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasisMV Yigit, SK Ghosh, M Kumar, V Petkova, A Kavishwar, A Moore, ...Oncogene 32 (12), 1530-1538, 2013862013
2-) Monoclonal Immunoglobulin G1 Directed against Aspergillus fumigatus Cell Wall Glycoprotein Protects against Experimental Murine AspergillosisAK Chaturvedi, A Kavishwar, GB Shiva Keshava, PK ShuklaClinical and Vaccine Immunology 12 (9), 1063-1068, 2005792005
3-) Combining miR-10b–targeted nanotherapy with low-dose doxorubicin elicits durable regressions of metastatic breast cancerB Yoo, A Kavishwar, A Ross, P Wang, DP Tabassum, K Polyak, ...Cancer research 75 (20), 4407-4415, 2015642015
4-) Curcumin analogues as selective fluorescence imaging probes for brown adipose tissue and monitoring browningX Zhang, Y Tian, H Zhang, A Kavishwar, M Lynes, AL Brownell, H Sun, ...Scientific reports 5 (1), 13116, 2015462015
5-) Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancerB Yoo, A Kavishwar, P Wang, A Ross, P Pantazopoulos, M Dudley, ...Scientific reports 7 (1), 45060, 2017452017